158 related articles for article (PubMed ID: 19390595)
1. The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic rat.
Baynes JW; Murray DB
Exp Diabetes Res; 2009; 2009():696378. PubMed ID: 19390595
[TBL] [Abstract][Full Text] [Related]
2. Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment.
Lu J; Pontré B; Pickup S; Choong SY; Li M; Xu H; Gamble GD; Phillips AR; Cowan BR; Young AA; Cooper GJ
Cardiovasc Diabetol; 2013 Jan; 12():28. PubMed ID: 23368770
[TBL] [Abstract][Full Text] [Related]
3. A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.
Cooper GJ; Young AA; Gamble GD; Occleshaw CJ; Dissanayake AM; Cowan BR; Brunton DH; Baker JR; Phillips AR; Frampton CM; Poppitt SD; Doughty RN
Diabetologia; 2009 Apr; 52(4):715-22. PubMed ID: 19172243
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and renal function are progressively impaired with aging in Zucker diabetic fatty type II diabetic rats.
Baynes J; Murray DB
Oxid Med Cell Longev; 2009; 2(5):328-34. PubMed ID: 20716921
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
6. Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.
Zhang L; Ward ML; Phillips AR; Zhang S; Kennedy J; Barry B; Cannell MB; Cooper GJ
Cardiovasc Diabetol; 2013 Aug; 12():123. PubMed ID: 23981320
[TBL] [Abstract][Full Text] [Related]
7. Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats.
Keegan A; Cotter MA; Cameron NE
Free Radic Biol Med; 1999 Sep; 27(5-6):536-43. PubMed ID: 10490273
[TBL] [Abstract][Full Text] [Related]
8. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.
Daniels A; Linz D; van Bilsen M; Rütten H; Sadowski T; Ruf S; Juretschke HP; Neumann-Haefelin C; Munts C; van der Vusse GJ; van Nieuwenhoven FA
Eur J Heart Fail; 2012 Feb; 14(2):193-201. PubMed ID: 22253456
[TBL] [Abstract][Full Text] [Related]
9. Effects of trientine, a metal chelator, on defective endothelium-dependent relaxation in the mesenteric vasculature of diabetic rats.
Inkster ME; Cotter MA; Cameron NE
Free Radic Res; 2002 Oct; 36(10):1091-9. PubMed ID: 12516881
[TBL] [Abstract][Full Text] [Related]
10. Regeneration of the heart in diabetes by selective copper chelation.
Cooper GJ; Phillips AR; Choong SY; Leonard BL; Crossman DJ; Brunton DH; Saafi 'L; Dissanayake AM; Cowan BR; Young AA; Occleshaw CJ; Chan YK; Leahy FE; Keogh GF; Gamble GD; Allen GR; Pope AJ; Boyd PD; Poppitt SD; Borg TK; Doughty RN; Baker JR
Diabetes; 2004 Sep; 53(9):2501-8. PubMed ID: 15331567
[TBL] [Abstract][Full Text] [Related]
11. Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.
van den Brom CE; Bosmans JW; Vlasblom R; Handoko LM; Huisman MC; Lubberink M; Molthoff CF; Lammertsma AA; Ouwens MD; Diamant M; Boer C
Cardiovasc Diabetol; 2010 Jun; 9():25. PubMed ID: 20550678
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin Protects Cardiac Function by Reducing Nitroxidative Stress and Promoting Autophagy in Zucker Diabetic Fatty (ZDF) Rats.
Zhou Y; Wang H; Man F; Guo Z; Xu J; Yan W; Li J; Pan Q; Wang W
Cardiovasc Drugs Ther; 2018 Dec; 32(6):541-552. PubMed ID: 30328028
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus.
Radovits T; Korkmaz S; Loganathan S; Barnucz E; Bömicke T; Arif R; Karck M; Szabó G
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H125-33. PubMed ID: 19429826
[TBL] [Abstract][Full Text] [Related]
14. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
[TBL] [Abstract][Full Text] [Related]
15. Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.
La Bonte LR; Davis-Gorman G; Stahl GL; McDonagh PF
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1282-90. PubMed ID: 18178726
[TBL] [Abstract][Full Text] [Related]
16. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
[TBL] [Abstract][Full Text] [Related]
17. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.
Kristiansen SB; Løfgren B; Støttrup NB; Khatir D; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Flyvbjerg A
Diabetologia; 2004 Oct; 47(10):1716-21. PubMed ID: 15480537
[TBL] [Abstract][Full Text] [Related]
18. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
[TBL] [Abstract][Full Text] [Related]
19. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.
Cameron NE; Cotter MA
J Clin Invest; 1995 Aug; 96(2):1159-63. PubMed ID: 7635953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
